PW Medtech Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7306W1087
HKD
1.34
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 69.46

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 23.04%

 
3

Negative results in Dec 24

4

With ROE of 4.97%, it has a Attractive valuation with a 0.52 Price to Book Value

5

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 1,901 Million ()

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.65%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

4.60%

stock-summary
Price to Book

0.43

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.29%
0%
-4.29%
6 Months
-4.29%
0%
-4.29%
1 Year
44.09%
0%
44.09%
2 Years
67.5%
0%
67.5%
3 Years
119.67%
0%
119.67%
4 Years
26.42%
0%
26.42%
5 Years
148.15%
0%
148.15%

PW Medtech Group Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.04%
EBIT Growth (5y)
42.60%
EBIT to Interest (avg)
69.46
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.13
Tax Ratio
16.20%
Dividend Payout Ratio
92.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
8.97%

Valuation key factors

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.52
EV to EBIT
2.89
EV to EBITDA
1.54
EV to Capital Employed
0.17
EV to Sales
0.50
PEG Ratio
NA
Dividend Yield
1.42%
ROCE (Latest)
5.96%
ROE (Latest)
4.97%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by PW Medtech Group Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 19.49% vs 90.86% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 51.17% vs -83.17% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "746.00",
          "val2": "624.30",
          "chgp": "19.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "268.40",
          "val2": "165.20",
          "chgp": "62.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.50",
          "chgp": "-60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.30",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "226.60",
          "val2": "149.90",
          "chgp": "51.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "214.30%",
          "val2": "118.30%",
          "chgp": "9.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23stock-summary

Dec'23
Dec'22
Change(%)
Net Sales
746.00
624.30
19.49%
Operating Profit (PBDIT) excl Other Income
268.40
165.20
62.47%
Interest
0.20
0.50
-60.00%
Exceptional Items
-0.10
-0.30
66.67%
Consolidate Net Profit
226.60
149.90
51.17%
Operating Profit Margin (Excl OI)
214.30%
118.30%
9.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 19.49% vs 90.86% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 51.17% vs -83.17% in Dec 2022

stock-summaryCompany CV
About PW Medtech Group Ltd. stock-summary
stock-summary
PW Medtech Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available